Počet záznamů: 1  

Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis

  1. 1.
    SYSNO ASEP0476224
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevCyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis
    Tvůrce(i) Škopová, Karolína (MBU-M)
    Tomalová, Barbora (MBU-M) ORCID
    Kanchev, Ivan (UMG-J) RID
    Rossmann, Pavel (MBU-M)
    Švédová, Martina (MBU-M)
    Adkins, Irena (MBU-M)
    Bíbová, Ilona (MBU-M) RID
    Tomala, Jakub (MBU-M) RID, ORCID
    Mašín, Jiří (MBU-M) RID, ORCID
    Guiso, N. (FR)
    Osička, Radim (MBU-M) RID, ORCID
    Sedláček, Radislav (UMG-J) RID
    Kovář, Marek (MBU-M) RID, ORCID
    Šebo, Peter (MBU-M) RID, ORCID
    Číslo článkue00937-16
    Zdroj.dok.Infection and Immunity. - : American Society for Microbiology - ISSN 0019-9567
    Roč. 85, č. 6 (2017), s. 1-22
    Poč.str.22 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovaBordetella pertussis ; adenylate cyclase toxin-hemolysin ; cAMP intoxication
    Vědní obor RIVEE - Mikrobiologie, virologie
    Obor OECDMicrobiology
    Vědní obor RIV – spolupráceÚstav molekulární genetiky - Mikrobiologie, virologie
    CEPNV16-28126A GA MZd - Ministerstvo zdravotnictví
    GA13-14547S GA ČR - Grantová agentura ČR
    GA13-12885S GA ČR - Grantová agentura ČR
    GA15-09157S GA ČR - Grantová agentura ČR
    GAP302/12/0460 GA ČR - Grantová agentura ČR
    LM2015064 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    LM2015040 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaMBU-M - RVO:61388971 ; UMG-J - RVO:68378050
    UT WOS000405937200012
    EID SCOPUS85019930879
    DOI10.1128/IAI.00937-16
    AnotaceThe adenylate cyclase toxin-hemolysin (CyaA, ACT, or AC-Hly) of Bordetella pertussis targets phagocytic cells expressing the complement receptor 3 (CR3, Mac-1, αMbeta2 integrin, or CD11b/CD18). CyaA delivers into cells an N-terminal adenylyl cyclase (AC) enzyme domain that is activated by cytosolic calmodulin and catalyzes unregulated conversion of cellular ATP into cyclic AMP (cAMP), a key second messenger subverting bactericidal activities of phagocytes. In parallel, the hemolysin (Hly) moiety of CyaA forms cation-selective hemolytic pores that permeabilize target cell membranes. We constructed the first B. pertussis mutant secreting a CyaA toxin having an intact capacity to deliver the AC enzyme into CD11b-expressing (CD11b+) host phagocytes but impaired in formation of cell-permeabilizing pores and defective in cAMP elevation in CD11b- cells. The nonhemolytic AC+ Hly- bacteria inhibited the antigen-presenting capacities of coincubated mouse dendritic cells in vitro and skewed their Toll-like receptor (TLR)-triggered maturation toward a tolerogenic phenotype. The AC+ Hly- mutant also infected mouse lungs as efficiently as the parental AC+ Hly+ strain. Hence, elevation of cAMP in CD11b- cells and/or the pore-forming capacity of CyaA were not required for infection of mouse airways. The latter activities were, however, involved in bacterial penetration across the epithelial layer, enhanced neutrophil influx into lung parenchyma during sublethal infections, and the exacerbated lung pathology and lethality of B. pertussis infections at higher inoculation doses (more than 107 CFU/mouse). The pore-forming activity of CyaA further synergized with the cAMP-elevating activity in downregulation of major histocompatibility complex class II (MHC-II) molecules on infiltrating myeloid cells, likely contributing to immune subversion of host defenses by the whooping cough agent.
    PracovištěMikrobiologický ústav
    KontaktEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Rok sběru2018
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.